Details for New Drug Application (NDA): 021747

✉ Email this page to a colleague

NDA 021747 describes COMBIVENT RESPIMAT, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the COMBIVENT RESPIMAT profile page.

The generic ingredient in COMBIVENT RESPIMAT is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

Summary for 021747

Tradename:	COMBIVENT RESPIMAT
Applicant:	Boehringer Ingelheim
Ingredient:	albuterol sulfate; ipratropium bromide
Patents:	4

Pharmacology for NDA: 021747

Mechanism of Action	Adrenergic beta2-Agonists Cholinergic Antagonists

Suppliers and Packaging for NDA: 021747

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
COMBIVENT RESPIMAT	albuterol sulfate; ipratropium bromide	SPRAY, METERED;INHALATION	021747	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0024	0597-0024-02	1 CARTRIDGE in 1 CARTON (0597-0024-02) / 120 SPRAY, METERED in 1 CARTRIDGE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SPRAY, METERED;INHALATION			Strength	EQ 0.1MG BASE/INH;0.02MG/INH
Approval Date:	Oct 7, 2011	TE:		RLD:	Yes
Patent:	7,396,341	Patent Expiration:	Oct 10, 2026	Product Flag?	Y	Substance Flag?		Delist Request?	Y
Patent:	7,837,235	Patent Expiration:	Mar 13, 2028	Product Flag?	Y	Substance Flag?		Delist Request?	Y
Patent:	8,733,341	Patent Expiration:	Oct 16, 2030	Product Flag?	Y	Substance Flag?		Delist Request?	Y

Expired US Patents for NDA 021747

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	COMBIVENT RESPIMAT	albuterol sulfate; ipratropium bromide	SPRAY, METERED;INHALATION	021747-001	Oct 7, 2011	6,453,795	⤷ Get Started Free
Boehringer Ingelheim	COMBIVENT RESPIMAT	albuterol sulfate; ipratropium bromide	SPRAY, METERED;INHALATION	021747-001	Oct 7, 2011	7,246,615	⤷ Get Started Free
Boehringer Ingelheim	COMBIVENT RESPIMAT	albuterol sulfate; ipratropium bromide	SPRAY, METERED;INHALATION	021747-001	Oct 7, 2011	6,977,042	⤷ Get Started Free
Boehringer Ingelheim	COMBIVENT RESPIMAT	albuterol sulfate; ipratropium bromide	SPRAY, METERED;INHALATION	021747-001	Oct 7, 2011	5,911,851	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.